Over 10 years experience of Traceability Solutions
By Pharmatrax Author
Category: Technoloy
No CommentsThe current recorded case count for COVID-19 (coronavirus) in the UK has hit 93,873 with 12,107 deaths. Health communications group Page & Page has teamed…
By Pharmatrax Author
Category: Technoloy
No CommentsBoehringer partners Insilico for AI-based discovery of drug targets. Credit: Madras150. Insilico Medicine has partnered with Boehringer Ingelheim to leverage artificial intelligence (AI) technology to…
By Pharmatrax Author
Category: Technoloy
No CommentsDespite decades of research and therapeutic advances, cancer remains a global scourge and is currently the second leading cause of mortality. According to the American…
By Pharmatrax Author
Category: Technoloy
No CommentsFor a few years, thought leaders across the global economy have invested hopes that blockchain, the record-keeping technology behind Bitcoin, could bring transparency across the…
By Pharmatrax Author
Category: Technoloy
No CommentsLarge pharmaceuticals are hoarding data needed for a coronavirus cure. There is a precedent to share it, and retain commercial confidentiality. In brief Some of…
By Pharmatrax Author
Category: Technoloy
No CommentsTech Nation provides an extensive roundup of UK healthtech companies that are tackling the coronavirus pandemic via innovative solutions How are UK healthtech companies fighting…
By Pharmatrax Author
Category: Technoloy
No Comments3D printing is revolutionizing the medical field as we know it. The market is expected to rocket up 308% to $44.4 billion in 2025. I’ll…
By pharmatrax
Category: Technoloy
No CommentsAs its latest trials move into next phase, founder and A HealthTech firm using AI to speed up the creation of treatments for rare diseases…
By pharmatrax
Category: Technoloy
No CommentsThe survey indicates that almost all respondents were concerned about the COVID-19 pandemic’s effects on company performance, including supply and demand failures. A survey of…
By pharmatrax
Category: Technoloy
No CommentsA new study leverages an established AI-based drug discovery pipeline to produce molecular structures as part of the widening fight against the 2019-nCoV outbreak. Researchers…